YOLFTbeta
20

Hana Must SPAC 2

208370 · KQ · Healthcare / Medical Devices

2,330.00KRW-70.00 (-2.92%)

Price History

Full chart

Market Stats

Previous Close2,400.00
Open2,430.00
Day Range2,315.00 – 2,500.00
52-Week Range2,130.00 – 7,490.00
Volume506.10K
Market Cap68.79B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.71
50-Day Avg2,509.40
200-Day Avg3,916.20

About

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers. Its products are used in hospitals, medical facilities, doctor's offices, weight loss centers, Fitness Centers, nursing homes, public health facilities, and retail locations. The company was formerly known as Jawon Medical Co., Ltd. and changed its name to SELVAS Healthcare, Inc. in September 2016. SELVAS Healthcare, Inc. was founded in 1993 and is headquartered in Daejeon, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Chul-Joong Kwon
  • Employees128
  • Headquarters155, Sinseong-ro, Daejeon, South Korea, 34109, Korea
  • Websitehttps://www.selvashealthcare.com

Leadership

  • Mr. Chul-Joong KwonCEO & Director · b. 1965
  • Mr. Byung-Tak YooCEO & Director · b. 1974
  • Mr. Woo-Jae LeeMD & Chief of Marketing Office · b. 1969
  • Mr. Haeseok LeeExecutive Director · b. 1980
  • Mr. Min-Cheol KwakExecutive Director · b. 1975

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue20.85B23.09B29.58B20.03B22.35B21.15B29.09B27.69B29.81B31.70B30.82B
Growth (%)-+10.71%+28.11%-32.29%+11.61%-5.36%+37.52%-4.82%+7.68%+6.34%-2.77%
Cost of Revenue10.19B13.92B16.65B16.30B13.89B11.39B15.13B13.57B14.16B15.14B15.83B
Gross Profit10.67B9.17B12.93B3.73B8.46B9.76B13.96B14.12B15.65B16.56B15.00B
Gross Margin51.16%39.72%43.70%18.63%37.87%46.13%47.99%51.00%52.50%52.24%48.66%
Operating Expense10.68B17.52B12.78B22.77B11.91B8.90B10.66B12.18B12.30B13.29B15.16B
Operating Income-11.01M-8.35B148.88M-19.04B-3.45B858.17M3.30B1.94B3.35B3.27B-161.56M
Operating Margin-0.05%-36.16%0.50%-95.07%-15.42%4.06%11.35%7.01%11.22%10.33%-0.52%
EBITDA-------4.46B5.10B4.58B5.88B
EBITDA Margin-------16.12%17.09%14.46%19.06%
Net Income166.90M-14.87B-1.12B-19.99B-3.33B758.70M2.47B2.81B5.17B3.15B3.89B
Net Income Margin0.80%-64.41%-3.77%-99.83%-14.89%3.59%8.50%10.16%17.34%9.94%12.62%
R&D1.25B2.81B2.42B3.64B1.82B1.87B2.33B2.79B3.11B3.16B3.68B
R&D as % of Total Revenue5.97%12.19%8.19%18.18%8.14%8.86%8.03%10.08%10.44%9.97%11.92%
Interest Expense0000896.19M697.85M639.50M511.12M227.23M236.17M89.73M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%4.01%3.30%2.20%1.85%0.76%0.74%0.29%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets47.25B45.48B54.70B41.26B47.11B45.14B48.98B45.11B66.68B70.22B78.99B
Total Liabilities28.16B18.57B26.88B26.65B22.97B20.24B20.92B12.21B6.58B6.42B7.86B
Total Equity19.09B26.92B27.81B14.60B24.14B24.89B28.06B32.89B60.10B63.80B71.13B
Cash9.22B4.71B3.29B1.43B12.94B9.64B67.00K71.00K9.82B57.00K9.38B
Total Debt---10.56B8.43B6.95B-----
Net Debt----5.83B6.50B6.36B3.08B---

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-164.29M-6.23B-4.30B-6.90B3.69B4.23B2.93B50.81M3.47B4.50B304.75M
Investing Cash Flow--191.52M7.41B-7.85B-635.37M1.07B-4.68B-1.38B2.23B-13.97B-594.13M-
Financing Cash Flow11.02B24.79B-5.62B10.83B5.69B6.77B-2.80B-1.38B-7.83B15.95B-687.85M-
Capital Expenditure0665.29M5.09B8.25B677.06M133.47M137.63M376.00M360.64M368.90M736.89M1.10B
Free Cash Flow-----4.45B4.09B2.55B-309.84M3.10B3.76B-796.94M
FCF to OCF-----120.81%96.68%87.16%-609.86%89.37%83.62%-261.50%

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Mar 30, 2016Mar 31, 2016Aug 12, 2016Nov 11, 2016Feb 23, 2017May 15, 2017Aug 14, 2017Nov 13, 2017Feb 19, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 28, 2019May 15, 2019Aug 14, 2019Nov 11, 2019Feb 12, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------
EPS Actual18.6833.2151.9937.4828.87-36.75-1957.20-377.58-26.3116.3115.75-91.15-228.00-39.00-141.00-448.00-146.69-96.11-34.3590.33-16.8112.2930.587.80-78.4337.1893.3558.2530.1053.4047.51-62.4734.0668.2571.4240.6325.907.608.2981.177.52-17.7519.74141.16511.74-337.38
Surprise----------------------------------------------
Timing---Pre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hours--------------------------

Key Statistics & Ratios

Market Cap68.79B
Enterprise Value35.32B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.17
Price / Book0.80
Revenue (TTM)31.69B
Gross Profit (TTM)15.55B
EBITDA2.54B
Profit Margin27.45%
Operating Margin4.54%
Return on Equity12.50%
Return on Assets1.25%
Shares Outstanding25.72M
Shares Float15.51M
Beta-0.71
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 11, 20231121:1084
  • Feb 7, 20171:5